Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Nimotuzumab in Combination With TPF for Head and Neck Squamous Cell Carcinoma

NCT01425736 is registered in ClinicalTrials.gov with Wei Guo as lead sponsor.

NCT NCT01425736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01425736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Nimotuzumab in Combination With TPF for Head and Neck Squamous Cell Carcinoma
Lead sponsor
Wei Guo
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2009
Completion date
March 31, 2013
Enrollment
91 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck squamous cell carcinoma